Idris Oncology one of first companies to receive free human tissue through Codex4SME’s
The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application.
“It is always hard for SME’s to obtain human samples of any kind,” says Idris CEO and founder Hans Peter Mulder. “That’s why we are so happy with the support from Codex4SME’s and its regional partner InnovationQuarter. What has really speeded Idris’ product development is the fact that Codex4SME’s also covers the costs and assists with the supply form BioBank Graz. This way we can treat cancer better.”
“I’m very happy that Idris was one of the first to obtain these free samples* as it will help making cancer treatment to become more personalized,” says Stéfan Ellenbroek, senior business developer Life Sciences and Health at InnovationQuarter. “There are currently a couple of other Zuid-Holland companies in discussion with the BioBank Graz for prospective tissue collection, but I also urge the rest of the ecosystem to check out this nice chance as the vouchers for free samples are limited in amount. Any companies with questions can contact me!”
*Costs covered through the Codex4SME’s Inttereg NWE grant. All tissues are obtained with informed consent.